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Abstract
Follicular dendritic cells (FDC) are non-lymphoid,
non-phagocytic accessory cells in the immune system that
are essential for antigen presentation and germinal center
reaction regulation1. These cells are CD21+, CD35+, CD1a-
and S100 protein + and they show desmosomes ultrastruc-
turally.
The most commonly involved sites by FDC tumors
are lymph nodes but may arise at a variety of extranodal
sites including oral cavity, tonsil, gastrointestinal tract and
liver. Most studies represent single case reports or case
series. 
Our patient presented with tumor in the lymph
nodes. Histology revealed tumor cells with abundant
eosinophilic cytoplasm, hyperchromatic and pleomorphic
nuclei, and prominent nucleoli. The tumor cells were found
to be positive for CD21 which is a specific marker for fol-
licular dendritic cells.
Introduction
Follicular dendritic cells (FDC) are non-lymphoid,
non-phagocytic accessory cells in the immune system that
are essential for antigen presentation and germinal center
reaction regulation.1 They form tight meshworks within
lymphoid follicles. These cells are CD21+, CD35+, CD1a-
and S100 protein + and they show desmosomes ultrastruc-
turally.
Neoplasms showing FDC differentiation were first
recognized by Monda et al in 1986.2 The most commonly
involved sites are lymph nodes but may arise at a variety of
extranodal sites including oral cavity, tonsil, gastrointestinal
tract and liver. Most studies represent single case reports or
case series. The apparent rarity may be explained in part by
under-recognition of the entity.3
Histologically FDC tumor is composed of spindle to
ovoid cells that are arranged in fasicles, storiform patterns
and whorls. The individual neoplastic cells generally have
plump, slightly eosinophilic cytoplasm with indistinct cell
borders. The nuclei are elongated, with vesicular or granu-
lar finely dispersed chromatin, small but distinct nucleoli,
and a delicate nuclear membrane. Lymphocytes are charac-
teristically sprinkled throughout the tumor. Nonetheless, the
recognized morphologic spectrum of FDC sarcoma has
broadened over the years, such as endocrine tumor like vas-
culature, polygonal cells, hyaline cytoplasm, and myxoid
stroma; and a definitve diagnosis always requires confirma-
tion by immunohistochemical and/ or ultrastructural stud-
ies.4
We report a case of follicular dendritic cell sarcoma
of the lymph node.
Case Report
We describe a 46 year old male having cervical lym-
phadenopathy since two months. There was no history of
generalized lymphadenopathy. General physical and sys-
temic examination was unremarkable. No visceromegaly
was present. Haematological examination revealed
Haemoglobin 13.8gm/dl, Haematocrit 40%, TLC 6x109/L
and Platelets 320x109/L. Excisional biopsy of the lymph
node was done which showed effacement of the nodal archi-
tecture by a neoplastic lesion exhibiting sheets of large
tumor cells with moderate amount of cytoplasm. Spindly
appearance of the tumor cells was also noted. The nuclei
showed moderate to severe pleomorphism and hyperchro-
masia (Figure 1). Occasional prominent nucleoli were seen.
Abundant mitotic figures were present. No glycogen posi-
tivity was seen on special stains. Initial panel of immunohis-
tochemistry was negative for epithelial markers (cytokeratin
MNF, CK Cam 5.2, EMA) and Lymphoid panel (LCA, Pan
B markers; CD 20 and CD 79a, Ki-1, CD 30, ALK protein)
and S-100, CD 68, CD31, CD34, HMB45, Vimentin,
ASMA and Desmin. The only  positive mother was CD 21
(Figure 2). The case was diagnosed as Follicular dendritic
cell sarcoma/tumor according to WHO/REAL classification
system.
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Figure 1:H & E Sections showing effaced nodal architecture by large tumor cells with moderate
cytoplasm and pleomorphic nuclei. (Mag 20x)
Discussion
Monda et al2 first described Follicular dendritic
cell tumor (FDC), since then several other individual
cases and small series have been reported.3-7 It is usually
a disease of young and middle aged adults with no sex
predilection.
FDC is a low grade malignant neoplasm and distant
metastases have been described3. The local recurrence rate
is 40% and metastatic rate is 25%.8 When FDC sarcoma
metastasizes, the lung is a predilection site in addition to
lymph node and liver.3
Our patient presented with tumor in the lymph nodes.
Histology revealed tumor cells with abundant eosinophilic
cytoplasm, hyperchromatic, pleomorphic and prominent
nucleoli. The tumor cells were found to be positive for CD21
which is a specific marker for follicular dendritic cells.
The differential diagnosis depends, in part, on the
tumor location and may include thymoma, large cell lym-
phoma, peripheral nerve sheath tumor, histiocytic lym-
phoma, Langerhan's cell histiocytosis, spindle cell carcino-
ma and a variety of other mesenchymal lesions. The diagno-
sis should be confirmed with the use of immunohistochem-
istry, especially in extranodal organs.
Little is known about the etiology of FDC sarcoma.
There is an association of FDC sarcoma with Castleman dis-
ease of hyaline-vascular type.4,9 The tumor has been found
to be associated with EBV in cases occurring predominant-
ly in liver and spleen7,10 usually in cases with an inflamma-
tory pseudotumour like appearance.
In conclusion, FDC sarcoma is a rare entity and
awareness of this tumor requires an alert mind, especially if
a preliminary panel of immunostains fails to reveal cytoker-
atin expression.
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Figure 2. Membrane staining of the tumor cells by CD 21 antibody. (Mag 40x)
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